This site is intended for health professionals only

Key questions on ovarian and breast cancer genetics (1.5 CPD hours)

23 May 2014

FULL CPD MODULE

This module will update your knowledge on ovarian and breast cancer genetics, including:

The reliability of negative genetic testing
Risk reduction strategies that moderate/high-risk women should consider
The implications regarding contraception and HRT for women at high or moderate risk
Who should be considered for chemoprevention or prophylactic mastectomy
Who would warrant genetic testing for the BRCA1 or BRCA2 gene

Visit Pulse Reference for details on 140 symptoms, including easily searchable symptoms and categories, offering you a free platform to check symptoms and receive potential diagnoses during consultations.